SUNITINIB SANDOZ 50 MG CPS DUR 30

What is the maximum co-payment for SUNITINIB SANDOZ?

If the insurance company contributes, the maximum co-payment is 101 825,40 Kč. The maximum pharmacy price is 117 443,23 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does SUNITINIB SANDOZ have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

15 617,83 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Sunitinib je hrazen v léčbě pacientů: 1) s gastrointestinálním stromálním tumorem (GIST) po selhání léčby imatinibem pro neúčinnost nebo intoleranci, kteří vykazují ECOG performance status 0-1. 2) s nemetastatickým karcinomem ledviny T4, N0 – 1, M0 inoperabilním či s ponechaným pooperačním nádorovým reziduem, nebo s metastatickým karcinomem ledviny s jakýmkoliv T i N a M1, a) u pacientů s nízkým a středním rizikem v 1. linii léčby, b) ve 2. linii léčby. Pacienti musejí být ve výkonnostním stavu ECOG 0-1. Kontrola účinnosti léčby u pokročilého či metastatického karcinomu ledviny u pacientů se provádí 1x za 3 cykly jakoukoliv dostupnou zobrazovací metodou. Indikací k ukončení léčby je progrese onemocnění.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe SUNITINIB SANDOZ?

Prescription is not conditional on a medical specialization.

What is the composition of SUNITINIB SANDOZ?

Sunitinib (50 mg), neznámá látka s kódem 3755, mannitol, sodná sůl kroskarmelosy, povidon, magnesium-stearát, černý oxid železitý, červený oxid železitý, žlutý oxid železitý, oxid titaničitý, želatina, šelak, propylenglykol. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to SUNITINIB SANDOZ?

The medicine belongs to ATC group L01EX01 – SUNITINIB. Medicines with the same active substance can be found here.

Who manufactures SUNITINIB SANDOZ?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 5. 8. 2025. Production was terminated with effect from 30. 3. 2026. The manufacturer lists medicines with the following code as a potential substitute: